Tag: work

Categories
Business

AstraZeneca’s Vaccine Does Not Work Effectively Towards Virus Variant in South Africa

AstraZeneca’s Vaccine Does Not Work Well Against Virus Variant in South Africa

South Africa stopped using the AstraZeneca-Oxford coronavirus vaccine on Sunday after it was found the vaccine did not protect volunteers in clinical trials from mild or moderate illnesses caused by the more contagious variant of the virus first observed there.

The results were a devastating blow to the country’s efforts to fight the pandemic.

Scientists in South Africa said Sunday that a similar problem existed for people infected with previous versions of the coronavirus: the immunity they gained naturally did not seem to protect them from mild or moderate cases than what they were known to have Variant were re-infected as B.1.351.

The developments that occurred almost a week after a million doses of the AstraZeneca-Oxford vaccine hit South Africa were a huge blow to the country, where more than 46,000 people are known to have died from the virus.

They were also another sign of the dangers posed by new mutations in the coronavirus. Variant B.1.351 has spread to at least 32 countries, including the USA.

The number of cases evaluated as part of the studies outlined by South African scientists on Sunday was small, making it difficult to determine exactly how effective the vaccine might or might not be against the variant.

And because the clinical trial participants studied were relatively young and likely not to get seriously ill, it was impossible for the scientists to determine whether the variant affected the AstraZeneca-Oxford vaccine’s ability to protect against severe Covid-19, hospitalization, or death.

However, the scientists said they believed the vaccine might protect against more severe cases based on the immune responses seen in blood samples from people who were given it. If further studies show this is the case, South African health officials will consider resuming use of the AstraZeneca-Oxford vaccine, they said.

The new research results were not published in a scientific journal. The discovery that the AstraZeneca-Oxford product has only minimal effectiveness in preventing mild and moderate cases of the new variant contributed to the growing evidence that B.1.351 makes current vaccines less effective.

Pfizer and Moderna have both said that preliminary laboratory studies show that while their vaccines are still protective, they are less effective against B.1.351. Novavax and Johnson & Johnson have also sequenced test samples from their clinical trial participants in South Africa, where B.1.351 caused the vast majority of cases, and both reported less efficacy than in the US.

“These results are really a reality check,” said Shabir Madhi, a virologist at Witwatersrand University who conducted the AstraZeneca-Oxford vaccine study in South Africa, of the results released on Sunday.

The pause in the introduction of the AstraZeneca-Oxford vaccine in the country means that first deliveries are now being made in warehouses.

Instead, South African health officials said they would be vaccinating health workers with the Johnson & Johnson vaccine in the coming weeks, which has shown strong effectiveness in preventing severe cases and hospitalizations caused by the new variant.

Johnson & Johnson has applied for an emergency permit in South Africa. However, the local health authorities said that some health workers could receive the vaccine before its approval as part of an ongoing study.

In the AstraZeneca-Oxford study in South Africa, around 2,000 participants received either two doses of the vaccine or placebo injections.

There was virtually no difference in the number of people in the vaccine and placebo groups infected with B.1.351, suggesting that the vaccine did little to protect against the new variant. Nineteen of the 748 people in the group who received the vaccine were infected with the new variant, compared with 20 of 714 people in the group who were given a placebo.

This equates to a vaccine effectiveness of 10 percent, although the scientists didn’t have enough statistical confidence to know for sure whether that figure would apply to more people.

The researchers also conducted laboratory experiments on blood samples from people who had been vaccinated and found a significant reduction in the levels of activity of vaccine-generated antibodies to the B.1.351 variant compared to other lineages.

Aside from the disturbing news about the AstraZeneca-Oxford vaccine, Dr. Madhi on evidence that previous infection from previous versions of the coronavirus did not protect people in South Africa from variant B.1.351.

To determine who was previously infected with the coronavirus, the researchers tested blood samples from people who had participated in a study of the Novavax vaccine but who were given placebo shots rather than the vaccine itself.

The researchers compared the infection levels of the new variant in people who were shown to have previously had Covid-19 with the infection levels in people who did not and found no difference.

Dr. Madhi wrote on a slide presented on Sunday evening that “an earlier infection by ‘original’ variants of SARS-CoV-2 does NOT protect against mild and moderate Covid-19 from the B.1.351 variant”.

He said it was possible that the B.1.351 variant’s potential to evade immune responses in previously infected people was at least partially responsible for why South Africa has suffered such a devastating second wave of the virus in recent months.

Oxford University researchers admitted on Sunday that the vaccine offers “minimal protection” against mild or moderate cases with variant B.1.351. They are working on a new version of the vaccine that can protect against the most dangerous mutations of variant B.1.351 and hope that it will be ready in the fall.

“This study confirms that, as expected, the pandemic coronavirus will find ways to spread further in vaccinated populations,” Andrew Pollard, lead investigator for the Oxford vaccine study, said in a statement. “Given the encouraging results of other studies in South Africa using a similar viral vector, vaccines can continue to reduce the burden on health systems by preventing serious diseases.”

Moderna has also started developing a new form of its vaccine that can be used as a booster shot against the variant in South Africa.

B.1.351 has become the dominant form of the virus in South Africa and has been found in several dozen countries. A small number of cases have been reported in South Carolina, Maryland, and Virginia.

Scientists believe that B.1.351 is better able to evade antibodies produced by vaccines because it has acquired a mutation known as E484K that makes it difficult for antibodies to capture the virus and prevent it from entering cells.

Novavax said its vaccine was almost 50 percent effective in preventing Covid-19 in its South Africa study. Johnson & Johnson reported that its single vaccine was 57 percent effective in preventing moderate to severe Covid-19 in South Africa, although it still offered full protection against hospitalization and death after four weeks.

Another fast-spreading variant of the virus, known as B.1.1.7 and first identified in the UK, does not appear to affect the vaccines. All five leading vaccines, and most recently AstraZeneca’s product, were found to offer similar protection against B.1.1.7 when compared to previous lines of the virus.

AstraZeneca’s vaccine has been approved by around 50 countries, including the UK, which has found dozens of cases of the variant first seen in South Africa.

In the US, regulators are waiting for data from a large late-stage clinical trial of the AstraZeneca-Oxford vaccine, which is expected to be published in March.

Categories
Politics

How Do the Nobel Peace Prize Nominations Work?

How Do the Nobel Peace Prize Nominations Work?

Unlike major Hollywood awards ceremonies where it’s really an honor to be nominated, the Nobel Peace Prize accepts submissions from a potential pool of thousands of nominees.

The Norwegian Nobel Committee, which selects the winner, does not announce the nominees or those who nominated them until 50 years later, so that participants can report their contributions at their own discretion.

After the deadline for this year’s nominations last Sunday, Aleksei A. Navalny, the Russian dissident leader; Greta Thunberg, the youth activist for climate change; and the World Health Organization were among the nominees, Reuters reported.

Also mentioned were Stacey Abrams, the former Georgian politician who was credited with increasing voter turnout last year, and Jared Kushner, son-in-law and advisor to former President Donald J. Trump. (Mr Trump himself has been nominated for the award in at least two years of his presidency – with no two nominations faked in 2018.)

Reuters polled Norwegian lawmakers “who have been shown to have chosen the winner”.

The list of those who can submit nominations is long, including members of national governments. Officials of international peace organizations; University professors in history, social sciences, law, philosophy, theology and religion; and former recipients.

The Nobel Committee says the large number of potential nominators ensures a “wide variety of candidates,” but the group is excited about the process and has not responded to a request for clarification on the suitability of nominators.

In 1967, the last year available in the Nobel Committee Archives, 95 nominations were received (an individual or group can be nominated multiple times in the same year). The committee said there were 318 submissions last year, up from a record 376 in 2016.

There are few criteria for nominees, and the process has sometimes been exploited for naked political reasons.

As is well known, an anti-fascist legislator from Sweden nominated Adolf Hitler in 1939 in an act of satire. He “never wanted his submission to be taken seriously,” says a note on his nomination in the archive.

Joseph Stalin, the leader of the Soviet Union, was nominated twice in 1945 and 1948. Benito Mussolini, the Italian ruler, was nominated twice in 1935.

The selection process for determining a recipient is much more rigorous. The committee appointed by the Norwegian Parliament will deliberate in secret from February. The group limits submissions to a “short list” of 20 to 30 candidates prior to months of examination. The recipient will be announced in October.

The Nobel Committee has stressed that nominations are not an endorsement of the group and “must not be used to imply membership of the Nobel Peace Prize”.

But Mr Trump provides an example of how nominations themselves can be used to gain influence.

In 2019, Mr Trump announced to his supporters that he had been nominated by then Japanese Prime Minister Shinzo Abe, a claim Mr Abe would not confirm. (This year’s award went to Abiy Ahmed, Prime Minister of Ethiopia.)

Last year, after two European leaders said they had nominated Mr. Trump, White House press secretary Kayleigh McEnany called it “a hard-earned and well-deserved honor for this president.”

The 2020 award was later awarded to the World Food Program.

Mr Trump was actually nominated by two right-wing Scandinavian MPs. For his followers, however, the personal politics of the nominators or their low likelihood of receiving the award were less important than their looks.

“Every day Donald Trump is nominated for another Nobel Prize,” beamed Fox News presenter Laura Ingraham on her show. “It is obvious that Trump should receive the Nobel Prize.”

At a campaign event in October, Mr Trump complained that his nomination received less coverage than his predecessor’s. (President Barack Obama actually received the award in 2009.)

“I was just nominated for the Nobel Prize,” he said. “And then I turned on the fake news story by story. They talk about your weather on the panhandle and they talk about it. Story after story, no mention. Do you remember when Obama got it right in the beginning and didn’t even know why he got it? “

The award for Mr Obama, just nine months into his first term, was received with surprise and confusion even by the recipient.

“To be honest,” Obama said afterwards, “I don’t feel like I deserve to be with so many of the transformative personalities who have won this award, men and women who inspire and inspire me have the whole world through their courageous pursuit of peace. “

Categories
Business

The Economist Putting Worth on Black Girls’s Neglected Work

The Economist Placing Value on Black Women’s Overlooked Work

The American business profession has begun to grapple with the diversity problems in its field. In June, as protests against Black Lives Matter raged in the US and then around the world, the American Economic Association – the voice of the establishment for economists – admitted that “our professional climate is hostile to black economists.”

Since a 2019 survey by the association, more diversity and inclusion initiatives, research pathways, and high-profile promotions have emerged that found experiences of sexual harassment and assault were “not uncommon” for women, and Asian, Black, and Latin American economists reported of “significantly worse” experiences of discrimination than their white colleagues.

Dr. Banks career bears these scars. Your studies with Dr. Alexander is the result of a career that has gone off course. Her original goal was to become a development economist, a field that studies the growth of low-income economies. In the 1990s, she was sexually molested by an economist while doing an internship with a US government agency that focused on development.

“Based on this experience, I decided not to do a development economy,” she said. Just over two years ago, Dr. Banks, encouraged by the #MeToo movement, at this workplace.

“When it came time to write a dissertation, I really wanted to focus on something that mattered to me,” she said. “Something that honors the long history of black women who work for the African American community.”

The legacy of this switch is evident in their latest article. Their goal is to develop a theory to elevate the community as a manufacturing facility that needs to be scrutinized as closely as any other work. And to highlight the long-lasting effects of these women.

It dates back to 1908 when the Atlanta Neighborhood Union was founded, which was run by black women to study the needs of their community and provide basic social and health services that the city did not provide. It inspired the Women’s Political Council in Montgomery, Ala., Which worked to increase voter registration and later participated in political protests, including the Montgomery bus boycott. It resembles some of the work that black women are doing today, as in Georgia, to register voters serving to improve their communities and reduce inequality, with notable consequences.

In 1985, a group of black women came together in Los Angeles to stop the construction of a toxic waste incinerator in their neighborhood and to recruit professors and health officials. Two years later, the city dropped its plans. The Affected Citizens of South Central Los Angeles Group continues to exist as a nonprofit that develops affordable housing, runs youth programs and cleans streets.

Categories
Business

Delaying second AstraZeneca vaccine dose does work, examine exhibits

Delaying second AstraZeneca vaccine dose does work, study shows

A health worker shows a vial of the Covid-19 coronavirus vaccine from AstraZeneca-Oxford at Patan Hospital near Kathmandu on January 27, 2021.

PRAKASH MATHEMA | AFP | Getty Images

The UK’s decision to postpone AstraZeneca University Oxford’s second shot of coronavirus vaccine has proven to be an effective strategy, according to results from a new study.

Oxford University researchers found that the Covid-19 vaccine was 76% effective at preventing symptomatic infection for three months after a single dose, and that the rate of effectiveness increased with a longer interval before the first and second dose.

“The effectiveness of the vaccine after a single standard dose of the vaccine from the 22nd to the 90th day post-vaccination was 76% … and the modeled analysis showed that protection did not diminish during this initial 3-month period,” said the Study that was reviewed by The Lancet Medical Journal and published as a preprint on Tuesday found.

The effectiveness rate increased to 82.4% when at least 12 weeks were before the second dose. When the second dose was given less than six weeks after the first, the rate of effectiveness was 54.9%.

“These analyzes show that greater vaccine effectiveness is achieved with a longer interval between the first and second dose and that a single dose of vaccine is highly effective in the first 90 days, which further supports current policy,” the report said .

The UK’s current strategy is to vaccinate as many people as possible with a single dose first and postpone the second dose for up to 12 weeks. The idea is that a first dose will provide at least some of the protection and allow more people to have access to the vaccines while their availability is limited.

The decision to delay the administration of a second booster dose has sparked controversy, with some questioning whether it might reduce the effectiveness of the vaccine in preventing severe Covid-19 infection.

However, the UK Joint Committee on Vaccination and Immunization supported the approach. The UK is also delaying the second dose of Pfizer BioNTech vaccine, a move vaccine makers have warned about, arguing that there is no data to support a delay.

The study also provided key data on whether the vaccine reduced transmission of the virus, a previously unknown and crucial question for policy makers looking to lift measures to lock down the economy.

Based on weekly swabs from volunteers in the UK study, a 67% reduction in transmission was found after the first dose of the vaccine.

Effective strategy

This latest study supports the UK Government’s decision and concludes that vaccination programs “aiming to vaccinate a large proportion of the population with a single dose, with a second dose given after a period of three months, are an effective strategy to reduce disease and may be the optimum for pandemic vaccine introduction when supply is limited in the short term. “

The study used additional data from ongoing clinical trials of the vaccine. A separate announcement from AstraZeneca on Wednesday showed that the vaccine also prevented serious illness from Covid-19, with no serious cases and no hospital stays more than 22 days after the first dose.

The vaccine was approved by the UK Medicines Agency on December 30th and, as a shot made in the UK, makes up most of the country’s previously hailed successful vaccination program.

The UK is well on its way to vaccinating its four top priority groups (those over 70, residents and workers in nursing homes, frontline health and social workers and the most clinically vulnerable), which number around 15 million people by mid-February to have.

By February 1, over 9.6 million people had received a first dose of the vaccine, and just under 500,000 had received two doses, according to government figures.

Professor Andrew Pollard, chief investigator of the vaccine study at Oxford and co-author of the study, said, “These new data provide an important review of the intermediate data used by more than 25 regulatory agencies, including MHRA and EMA, to grant vaccine emergency approval.”

“It also supports the policy recommendation of the Joint Vaccination and Immunization Committee for a 12-week prime-boost interval as it seeks the optimal approach to initiation and assures us that people will be protected before 22 days after a single are dose of the vaccine. “

The researchers also hope to release data on the new coronavirus variants in the coming days and expect the results to be broadly similar to those already reported by other vaccine developers: that the current vaccines are effective against mutations in the virus.

Germany, France and Sweden currently do not recommend the AstraZeneca vaccine for people over 65 because of insufficient study data on this age group. However, the vaccine maker and the UK government have defended the sting, saying the data available shows it is safe and effective. Further analysis will be available shortly.

Categories
Business

Pinduoduo Worker Deaths Ignites China Debate Over Work

Pinduoduo Employee Deaths Ignites China Debate Over Work

Lyu Xiaolin, an employee of a large Chinese tech company, said she had discussed the Pinduoduo deaths at length with colleagues who agreed that the idea of ​​unbearable work pressure was all too familiar.

“The conclusion was that this is too terrible and we need to cherish our own lives,” she said. “We should make sure we leave work earlier in the future.”

She herself had changed roles in her company, which she did not want to identify for fear of retaliation because her previous work often meant that she had to work until 11 or 12 a.m., sometimes even until 3 a.m. She was looking for therapy to alleviate the psychological stress.

China’s hypercompetitive work culture, especially in the tech world, has been a frequent cause of concern and criticism in recent years. While many once celebrated growth at all costs as the engine of China’s development, young workers have increasingly complained about the cost to their health and personal relationships.

This dissatisfaction clearly exploded in 2019 when simple technicians organized a rare online protest against the so-called “996” culture – working days that last six days a week from 9 a.m. to 9 p.m. – and increased awareness of China’s labor law, the working days of more than eight hours without overtime pay is generally prohibited. However, companies insist that the long hours are voluntary and the authorities, aware of unofficial mobilization, censored much of the discussion about the movement. The internet went on.

The debate has broken out again.

On January 3rd, an anonymous user of Maimai, a professional networking platform, wrote that a friend of Pinduoduo died unexpectedly and blamed the company. The post gained traction, and Pinduoduo confirmed that a worker surnamed Zhang died on December 29th on her way home.

There was no public explanation for the cause of death, but many online have linked it to overwork. Users found that Ms. Zhang had been working on a new online grocery product that Pinduoduo had been promoting, and that the company’s executive director, Colin Huang, had just been named China’s second richest person.

Categories
Business

The Work Diary of a Cinematic Chef

The Work Diary of a Cinematic Chef

6 p.m. Quit tonight at a reasonable hour. Jess is meeting a friend for an ice cold al fresco dinner at Meadowsweet, and I fully intend to have a beer, turn my brain off, and watch TV in my home theater.

8 p.m. I saw David Byrne’s American Utopia. Unsurprisingly, it was great. Next is “History of Swear Words”. Nicolas Cage beats it up wonderfully, but the editing is a bit of a scatter shot.

9:30 am I overslept, I’m really sore, and I’m not going to exercise this morning. Jess’s eye hurts like crazy, and it sounds a lot like it when I had a scratched cornea in college. I go to get her remedies and an eye patch. At least she’s looking forward to a light pirate cosplay.

10:30 am Three different episodes are due to be reviewed by sponsors on Monday, so I have to do an absolutely tremendous amount of editing. But I also have almost consecutive conference calls until 3 p.m. I’ll find out what I can between calls, but have to take care of my cute Cyclops upstairs if I can.

14 o’clock I crack my ankles, update (video editing software) Premiere and dig in. Fun fact: I’m currently editing shots of the leftover fried rice I have for lunch. Is that a fun fact? Well I enjoy it. This concludes the brown rice saga.

4:30 p.m. I am receiving and testing some new samples from my upcoming cookware range. It’s carbon steel pans that I find nervous when presenting them as an alternative to nonstick pans, but if you practice a little they will become your lifelong friends.

8 p.m. After a nice, uninterrupted piece of productivity, all three episodes are put together, music inserted and voice-over recorded. I really wanted to get it done before the weekend, but there are over eight hours of voice-over work left. I take a lunch break with my significant other and then see if I have any juice left to carry on.

21 clock No! I’m full of Thai takeout, had two mojitos, my voice is shot from all conference calls, and it’s Friday. It’s time to do what young lovers do: watch a pulpy murderous drama. We decide on “The Undoing”, snuggle up under our weighted duvet (yes, of course we have one, we’re stressful Brooklynite millennials) and watch Nicole Kidman continue her long career as a crushing artist. Before we pass out, I find out that “WandaVision” has just premiered, and I wake up so I can be careful. I’m glad I did, because Wanda describes an open four-course menu from the 1950s that I’d like to add to the “Binging” list of ideas!

Categories
Politics

Distinguished Attorneys Need Giuliani’s Legislation License Suspended Over Trump Work

Prominent Lawyers Want Giuliani’s Law License Suspended Over Trump Work

Dozens of prominent lawyers have signed a formal complaint requesting the suspension of Rudolph W. Giuliani’s bar license – the latest and loudest in a series of calls to reprimand him for his actions as President Donald J. Trump’s personal attorney.

The lawyers said Mr Giuliani crossed ethical boundaries in helping Mr Trump prosecute false allegations of election fraud and then delivered an incendiary speech reiterating those claims just before the January 6 uprising at the Capitol.

A draft complaint to the New York Supreme Court Appeals Committee accuses Mr. Giuliani of knowingly making false allegations about the election and calls for an investigation into “conduct involving dishonesty, fraud, deception or misrepresentation in or outside the court” .

Demands for Mr. Giuliani to be disciplined have increased in the weeks since the uprising and are only increasing now after Mr. Trump stepped down. The latest complaint, signed by a non-partisan who-is-who of legal figures from New York and beyond, is possibly the most serious condemnation of Mr Giuliani’s conduct to date.

The list included former acting US attorney general Stuart M. Gerson, former US district judges H. Lee Sarokin and Fern M. Smith, and two former attorneys general, Scott Harshbarger of Massachusetts and Grant Woods of Arizona. The complaint was also signed by prosecutors working for the same United States law firm for the Southern District of New York that Mr. Giuliani ran in the 1980s, including Christine H. Chung.

Ms. Chung, a member of the steering committee of Lawyers Defending American Democracy, the organization that made the complaint, said the group had reviewed Mr. Giuliani’s work on behalf of Mr. Trump and that it was a “targeted campaign for the going.” with a lie about a stolen election from the American people. “

“This is a man who once ran the highest law enforcement agency in this nation and he knows what is fraud and what is not,” said Ms. Chung, who did not work for the US law firm during Mr. Giuliani’s tenure. She added, “It is forbidden for a lawyer to attack the rule of law and it is dangerous.”

Ms. Chung said that by Thursday afternoon, more than 500 people had signed the complaint, which anyone could sign on the Lawyers Defending American Democracy website, and that she expected “thousands” more to add their names.

The complaint seeking the suspension of Mr Giuliani’s admission to exercise his right during an investigation into his conduct is one of several complaints that have been lodged with the Board of Appeal. It comes a week after New York Senator Brad Hoylman, chairman of the judiciary committee, urged the state judicial system to begin the formal process of revoking Mr. Giuliani’s legal license.

It could take months or even years to conduct the investigation and determine an appropriate sentence, largely due to procedural hurdles and the complexity of Mr Giuliani’s case, said Stephen Gillers, a law professor at New York University and an expert in legal ethics.

Mr Gillers said he hoped the court would conduct a thorough investigation suspending Mr Giuliani’s license as Mr Giuliani used his reputation as a lawyer to spread false accounts.

“It is a privilege and an honor to be a New York attorney, and in investigating Giuliani and possibly sanctioning him for his behavior, the courts are reiterating that fact,” Gillers said.

Mr Giuliani, who did not respond to requests for comment, discussed the complaints about his behavior on his radio show last week.

“I’ve been a prosecutor all my life – I’m not stupid,” he said. “I don’t want to get in trouble. And personally, I have a great sense of ethics. I hate it when people attack my integrity. “

In the weeks since the insurrection, Mr Giuliani also redoubled his allegations of electoral fraud, arguing on conservative talk radio and social media that the masses indicting the Capitol were left-wing radicals who were involved in a conspiracy around him and To discredit Mr. Trump.

The numerous demands for disciplinary action underscore the extent to which Mr Giuliani’s reputation has grown since his years as Federal Prosecutor for Organized Crime and his two terms as Mayor of New York City, during which he advocated law enforcement and emphasized cleaning, has changed the streets.

At Mr Trump’s rally on Jan. 6, not long before a violent mob stormed the Capitol, Mr Giuliani called for a “trial by battle” to address his discredited allegations of electoral fraud.

“I am ready to maintain my reputation, the president is ready to strengthen his reputation because we will find crime there,” said Giuliani.

In the complaint, Mr Giuliani is accused of holding on to his false allegations of widespread electoral fraud only on January 16, thereby sacrificing his reputation.

“Other lawyers have met ethical obligations by withdrawing from representing Mr Trump and his campaign,” the complaint said. “Mr. Giuliani not only gave the company his stature and attorney status, but he also shows no inclination to stop lying.”

Earlier this week, a person close to Mr Trump said Mr Giuliani would not be part of Mr Trump’s defense during his second Senate impeachment trial.

Categories
Business

Examine says many unable to return to work six months later

Study says many unable to return to work six months later

As the first step in the largest vaccination campaign in Argentina’s history, first line health workers are receiving the Russian Sputnik V vaccine against the coronavirus.

Patricio Murphy | SOPA pictures | LightRocket | Getty Images

LONDON – The largest global study to date on Long Covid found that many people who suffer from persistent illness after being infected with Covid-19 cannot work at full capacity six months later.

The term “Long Covid” refers to patients who, after initially contracting the virus, suffer from a prolonged illness with symptoms such as shortness of breath, migraines and chronic fatigue.

Public discourse on the pandemic has mainly focused on people with severe or fatal illness, with the ongoing medical problems either underestimated or misunderstood. However, recent studies have shown that an increasing number of Covid patients experience persistent symptoms, with some patients referring to themselves as “long-distance drivers”.

A preliminary study, published Tuesday on MedRxiv, is believed to be the largest collection of symptoms yet identified in the long Covid population.

In the non-peer-reviewed study, the researchers interviewed 3,762 people aged 18 to 80 from 56 countries to identify the symptoms and other problems resulting from the long Covid.

205 symptoms were recorded in 10 organ systems, with 66 symptoms followed over seven months. On average, the respondents had symptoms from nine organ systems.

What were the results of the study?

The most common symptoms after six months were: fatigue, post-exercise fatigue, and cognitive dysfunction, sometimes called brain fog.

Respondents with symptoms over six months had an average of 13.8 symptoms by the seventh month. This is evident from the study by members of patient-led research for COVID-19, a self-organized group of patients with long coviden who are also researchers.

Over 45% of respondents said they needed a reduced work schedule compared to their previous illness, and 22.3% said they were not working at the time of the survey due to their state of health. Almost 86% experienced relapses, with exercise, physical or mental activity, and stress identified as the main triggers.

The analysis was limited to suspected and confirmed Covid cases with an illness that lasted more than 28 days and started before June. This should allow for an examination of symptoms over an average of six months, the researchers said.

A woman wearing a protective face mask walks on the levee at Stanley Park on January 4, 2021 in Vancouver, Canada.

Andrew Chin | Getty Images Entertainment | Getty Images

“We mustn’t forget Long Covid,” said Dr. Gabriel Scally, President of Epidemiology at the Royal Society of Medicine, on Tuesday via Twitter.

“Thousands of new cases develop every day. Vaccination is critical, but it needs to be carried out effectively and backed by other control measures that the Independent Sage has tirelessly advocated,” said Scally, a member of the scientific group that provides scientific advice on the pandemic British government and public.

The results of the study come from countries across Europe adopting tough new health measures to contain the spread of the coronavirus.

According to the Johns Hopkins University, more than 85 million people worldwide have infected Covid with 1.85 million deaths.

Categories
Business

Unemployment Claims Stay Excessive as Thousands and thousands Nonetheless Wrestle to Discover Work

Unemployment Claims Remain High as Millions Still Struggle to Find Work

For many people, the economy will not improve noticeably for at least a few months. Ms Swonk expects attitudes to remain unchanged or decrease in December compared to November.

Updated

Jan. 3, 2021, 1:23 AM ET

“The entire labor market loses momentum at a critical point when cases rise,” she said.

Seasonally adjusted, the number of new government claims was 787,000, down from 806,000 the previous week.

The second stimulus

Answers to your questions about the stimulus calculation

Updated December 30, 2020

The economic aid package will issue payments of $ 600 and will distribute federal unemployment benefits of $ 300 for a minimum of 10 weeks. Find out more about the measure and what’s in it for you. For more information on how to get help, please visit our hub.

    • Do I get another incentive payment? Individual adults with adjusted gross income on their 2019 tax return of up to $ 75,000 per year will receive a payment of $ 600, and a couple (or someone whose spouse died in 2020) who earns up to $ 150,000 per year receives twice this amount. There is also a payment of $ 600 for each child for families who meet these income requirements. Individuals filing taxes with head of household status and earning up to $ 112,500 will also receive $ 600 plus the additional amount for children. People with incomes just above this level will receive a partial payment that decreases by $ 5 for every $ 100 of income.
    • When could my payment arrive? The finance department said on December 29 that it had started making direct deposits and would be mailing checks the next day. However, it will take a while for everyone to receive their money.
    • Does the agreement concern unemployment insurance? Legislators agreed to extend the length of time people can receive unemployment benefits and restart an additional federal benefit that is on top of the usual state benefits. But instead of $ 600 a week it would be $ 300. That will last until March 14th.
    • I am behind on my rent or expect to be soon. Do I get relief? The deal calls for $ 25 billion to be distributed by state and local governments to help backward tenants. In order to receive support, households must meet various conditions: the household income (for 2020) must not exceed 80 percent of the area median income; At least one household member must be at risk of homelessness or residential instability. and individuals must be eligible for unemployment benefits or face direct or indirect financial difficulties due to the pandemic. The agreement states that priority will be given to support for lower-income families who have been unemployed for three months or more.

Tighter state and local restrictions on restaurants and other businesses will weigh heavily on the labor market in the coming weeks, said Scott Anderson, chief economist at Bank of the West in San Francisco.

Mr. Anderson believes the monthly employment report will show the unemployment rate rose from 6.7 percent in November to 6.9 percent in December. The unemployment rate has fallen sharply from its high of 14.7 percent in April, but hiring has slowed as the economy has stalled in recent months.

The economy may have only created about 20,000 jobs in December, said Rubeela Farooqi, US chief economist at High Frequency Economics. That would mean a “huge slowdown from last month,” she added, as the wage bill rose 245,000.

Additionally, the pace of layoffs has remained high as industries like hospitality, travel, and entertainment struggle with the pandemic keeping many people at home, even in states and cities that haven’t placed many restrictions on businesses. In contrast, many employees who were able to work remotely emerged relatively unscathed from the economic turmoil.

The introduction of vaccines is a bright spot, as are positive economic signs such as rising stock prices and a booming real estate market. But it will be months before enough Americans can be vaccinated so that people can go to restaurants, events, and movie theaters without fear of infection.

Categories
Business

China Has All It Must Vaccinate Hundreds of thousands, Besides Proof Its Vaccines Work

China Has All It Needs to Vaccinate Millions, Except Proof Its Vaccines Work

Hospitals across China have almost everything that is needed for mass vaccination: millions of doses. Refrigerators to store them. Health care workers trained to manage them.

Anything but evidence that one of their vaccines is working.

Unlike their Western competitors, the Chinese companies have not released late-stage clinical trial data showing whether their vaccines are effective, and regulatory agencies in China have not officially approved them.

This hasn’t stopped local governments across the country from launching an ambitious vaccination campaign. The aim is to vaccinate 50 million people – roughly the population of Colombia – before the New Year holidays by mid-February, when hundreds of millions of people are expected to travel.

China, where the virus first emerged a year ago, will be making great – and scientifically unorthodox – efforts to prevent the outbreak from recurring. Although Beijing has not officially announced the vaccination target, the government has signaled that the rollout will be similar to the outbreak, through a top-down approach that can mobilize thousands of workers to produce the shots, too send and manage. Local officials were told that the trip was a “political mission”.

The campaign will focus on what China calls ‘key priority groups’ including doctors, hotel workers, border control personnel, Food warehouse and transport workers and travelers. Irene Zhang, a 24-year-old college student, received a vaccine in Hangzhou on December 22nd before going to graduate school in the UK next month.

“Because my situation is pretty urgent and all the students around me going abroad have accepted it, I think it is relatively reliable,” said Ms. Zhang.

Even before this current campaign, more than a million people had lined up for vaccinations, confusing scientists who warned that taking undetected vaccines poses potential health risks. Their efforts, which are now larger in scope, are similarly implemented on an ad hoc basis.

The southern province of Guangdong has 180,000 people – mostly workers who are involved with food Storage and transportation, quarantine facilities and border controls – had been vaccinated by December 22nd. 281,800 people had been vaccinated in eastern Zhejiang Province. In Wuhan, where the outbreak was first discovered, the government said it had designated 48 vaccination clinics for its emergency program that began Thursday.

China, which is testing five vaccines in phase 3 studies, has not provided any information from this final phase to prove the effectiveness of these vaccines. In contrast, the United States and Great Britain began vaccination after reviewing and approving such experimental data.

Instead, Chinese officials have made extensive statements with few details to reassure the public that the vaccines are safe and effective. Three of the vaccines are only approved for emergency use. Last month, Liu Jingzhen, the chairman of Sinopharm, a state-owned vaccine maker that has two vaccines in late studies, said none of the roughly 1 million people vaccinated so far had side effects and that “few had mild symptoms.”

The dates and approval are expected to be available within weeks. While there have been promising signs, there are limitations.

The UAE and Bahrain said this month that a vaccine made by Sinopharm was effective, although they provided few details on how the conclusions were drawn. Turkey said a vaccine from Sinovac, a private vaccine maker based in Beijing, had an efficacy rate of 91.25 percent, a result based on preliminary results from a small clinical study. Officials in Brazil said the Sinovac vaccine had an efficacy rate of over 50 percent but had postponed the publication of detailed data.

The extent and speed of the vaccination campaign are the result of a centralized public health infrastructure in an authoritarian system. During the crisis, China showed how it can mobilize thousands of workers to reach millions of people. it tested 11 million people in 10 days in Wuhan.

Updated

Apr. 29, 2020, 6:59 p.m. ET

Chinese vaccine manufacturers have worked to increase production, both for the country’s own needs and for global exports. The Chinese government has promised to produce 610 million cans by the end of the year and expects to produce more than a billion cans in the next year.

“If they say 50 million, they probably will,” said Jennifer Huang Bouey, a senior policy researcher at RAND Corporation and an epidemiologist. “The question is how much it would cost and what effect that would have.”

The whole effort took months of preparation. Since June, hospitals in Guangdong Province have started building vaccination clinics, equipping them with refrigerators and installing cold storage systems.

Sinopharm was doing exercises this month. During the test run, workers loaded boxes of the vaccines and ice packs, while the company official tracked the temperature of the vaccines in real time as they were shipped.

China has some advantages in introducing it. Unlike the Pfizer vaccine, the vaccines made by Sinopharm and Sinovac are based on traditional methods that use inactivated or weakened forms of the virus, making them easier to store and distribute.

But the pitfalls are numerous, as the US experience has shown. in the In the United States, just over two million people have received Covid-19 vaccine, well below the government’s 20 million target for this month. Hospitals had to prepare the frozen shots and find staff to occupy the clinics.

While China was preparing, local officials asked the number of people in the “key priority groups”. According to a government document from Xinchang County in Zhejiang Province, they had to “make sure there were no omissions.”

As recently as two months ago, it seemed that demand might exceed supply. The eastern city of Yiwu had offered 500 cans that were used within a few hours.

Ms. Zhang, the student, said She had initially hesitated about getting vaccinated because everyone around her told her to “wait and see”. Nevertheless, she tried to register in Yiwu, but could not secure a place.

Then on December 21st, Ms. Zhang heard that Hangzhou was launching its own vaccination campaign. She took a bullet train that evening and signed a lease with her friend in town because local authorities required proof of residence. The next day, she paid $ 35 and was shot by Sinovac.

According to Ms. Zhang, four or five people were waiting for the vaccine in the hospital. The process took an hour. This included registering, getting the shot, and waiting 30 minutes to see if any side effects occurred.

“Everything was very calm and tidy,” she said. Before she left, the doctor warned her: don’t shower. Don’t stay up late. Do not eat foods that may irritate your stomach.

The government has emphasized that the vaccination campaign is voluntary and that people have to pay for the vaccinations. Yanzhong Huang, a senior fellow on global health at the Council on Foreign Relations and a health care expert in China, noted that the two-dose regime could cost about $ 70, making it inaccessible to the rural poor.

China may also have trouble convincing people to take the vaccine. Scientists warn that the lack of transparency could spark fears about taking a new vaccine, especially in an industry with a history of quality scandals.

Tao Lina, a vaccine expert and former immunologist at the Shanghai Center for Disease Control and Prevention, said he knew several health care workers who turned down the shots. “In the minds of doctors, they believe that any drug that fails Phase 3 trials is unreliable,” Tao said.

Mr. Tao, who received a Sinopharm vaccine Monday, said he was confident the vaccines were safe and effective, reiterating officials’ comments that there had been no reports of serious side effects. But he added that companies could do better with their news.

“If you say it’s safe, you should come up with all kinds of evidence to show it’s safe,” he said.

Hminem Zhang, a 27-year-old sales rep at an internet company, said he wanted to get vaccinated because he had traveled to work and feared that the virus could reappear if the virus recurs. But he is concerned about the ones made in China because “not many people received them,” he said.

“I would like to wait a month or two for some official data to be released,” said Mr. Zhang, who is from Chongqing, southwestern town. “And then if there’s no news about side effects, I’ll get a chance.”

Liu Yi, Amber Wang, and Elsie Chen contributed to the research.